ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Weiding Wu
Matched on OpenAlex author ID A5107936006. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic. Last author DOI 10.3389/fimmu.2026.1782960↗
- Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. Last author DOI 10.1186/s13046-025-03563-9↗
- Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer. Co-author DOI 10.1007/s12672-023-00628-z↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kaizhou Jin · 2 shared papers, 2025–2026 · strength 0.59
- Jin Yan · 1 shared paper, 2026 · strength 0.36
- Saimeng Shi · 1 shared paper, 2025 · strength 0.23
- Qinglin Fei · 1 shared paper, 2025 · strength 0.23
- Duancheng Guo · 1 shared paper, 2025 · strength 0.23
- Jianhui Yang · 1 shared paper, 2025 · strength 0.23
- Long‐Yun Ye · 1 shared paper, 2025 · strength 0.23
- Quanxing Ni · 1 shared paper, 2023 · strength 0.17
- Zhiwen Xiao · 1 shared paper, 2023 · strength 0.17
- Cheng He · 1 shared paper, 2023 · strength 0.17
- Xianjun Yu · 1 shared paper, 2023 · strength 0.17
- Chen Liu · 1 shared paper, 2023 · strength 0.17
- Guopei Luo · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.